Search Results 1351-1360 of 7262 for cf
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
No family history of pancreatic disorders, celiac disease, cystic fibrosis. No history of acute infectious or inflammatory conditions requiring medical ...
Combinations of biological substances in brentuximab vedotin may be able to carry cancer-killing substances directly to Hodgkin lymphoma cells. Drugs used in ...
This study is being done to store blood, buccal (cheek) cells, genetic material including DNA (deoxyribonucleic acid) and RNA (ribonucleic acid), ...
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
The goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for treatment with axicabtagene ...
Phase 2a, Dose-ranging Study With PF-05221304 In Nonalcoholic Fatty Liver Disease (NAFLD) · Overview · Participation eligibility · Participating Mayo Clinic ...
Participation eligibility · Cystic fibrosis. · Cigarette smoking in the last 6 months. · Common Variable Immunodeficiency Disease. · EGPA or small vessel vasculitis ...
The primary purpose of this study is to assess the safety and tolerability of RP-6306 with FOLFIRI in patients with eligible advanced solid tumors, ...
Guidance for molecular targeted therapy will involve gene analysis of oncogenes and tumor suppressor genes. Results from these studies may provide the rationale ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.